comment

Rwanda Inks Deal With BioNTech To Set Up Vaccine Manufacturing Plant Worth Over $116m

Rwanda has signed a deal with BioNTech to build the first mRNA-based vaccines manufacturing plant in Africa, with construction starting in mid-2022 and an estimated cost of $116 million.
Once operational, the plant aims to produce at least 50 million vaccine doses annually, contributing to vaccine access and health security in Africa.

Rwanda to become hub for AI research in Africa